Abstract

BackgroundFN is a serious side-effect of myelotoxic chemotherapy. G-CSF prophylaxis decreases FN incidence and reduces related morbidity and mortality.PurposeEvaluate the budgetary impact of primary (PP) and secondary prophylaxis (SP) of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call